Epstein Secrets

chart o= what Medicaid and Medicare were billed in six of the cases. But the department has ye= to release the chart. It is under indefinite review, Bill Schwarz, a depa=tment spokesman, said, "to ensure confidential information is not compromised." Back to=top States scramble to get health-care law's insur

eutical companies that ma=e nearly all the IV solutions used in the United States. It was a rare unguarded c=mment. Ms. Spak — like a spokesman for Hospira, another giant in the fie=d — later insisted that all information about saline solution prices was private. In fact, manufacturers ar= required to

ceutical companies that make nearly all the IV solutions used in the United States. It was a rare unguarded comment. Ms. Spak — like a spokesman for Hospira, another giant in the field — later insisted that all information about saline solution prices was private. In fact, manufacturers are required to r

hart of what Medicaid and Medicare were billed in six of the cases. But the department has yet to release the chart. It is under indefinite review, Bill Schwarz, a department spokesman, said, “to ensure confidential information is not compromised.” Back to top States scramble to get health-care law’s insura

aceutical companies that make nearly all the IV solutions used in the United States. It was a rare unguarded comment. Ms. Spak — like a spokesman for Hospira, another giant in the field — later insisted that all information about saline solution prices was private. In fact, manufacturers are required to re

chart of what Medicaid and Medicare were billed in six of the cases. But the department has yet to release the chart. It is under indefinite review, Bill Schwarz, a department spokesman, said, "to ensure confidential information is not compromised." Back to top States scramble to get health-care law's insuranc